India to Kenya: Actinomycin Export Trade Route
India has recorded 49 verified shipments of Actinomycin exported to Kenya, representing a combined trade value of $14.6K USD. This corridor is served by 18 active Indian exporters, with an average shipment value of $299 USD. The leading Indian exporter is 3S CORPORATION, which accounts for 25% of total export value with 8 shipments worth $3.7K USD. On the buying side, TO THE ORDER OF INVOICE RAISED TO: is the largest importer in Kenya with $3.2K USD in purchases. The top 3 suppliers — 3S CORPORATION, ASPIDA LIFE SCIENCES PRIVATE LIMITED, SPECIALITY MEDICINES PRIVATE LIMITED — together control 62% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Kenya Actinomycin corridor is one of India's established pharmaceutical export routes, with 49 shipments documented worth a combined $14.6K USD. The route is dominated by 3S CORPORATION, which alone accounts for roughly 25% of all export value, reflecting the consolidated nature of India's actinomycin manufacturing sector.
Across 18 active suppliers, the average shipment value stands at $299 USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 84% of all shipments, consistent with actinomycin's non-urgent bulk-order profile.
Shipment activity peaks during October–December, with an average transit time of 30 days port-to-port. The route has recorded an annual growth rate of 34.7%, placing it at rank #15 among India's top actinomycin export destinations globally.
On the import side, key buyers of Indian actinomycin in Kenya include TO THE ORDER OF INVOICE RAISED TO:, To The Order, FOR THE ORDER OF RAKAGIY GROUP LIMITED and 21 others. TO THE ORDER OF INVOICE RAISED TO: is the single largest importer with 2 shipments valued at $3.2K USD.
